Marc Belsky insider trades
Open-market stock purchases and sales by Marc Belsky, Chief Financial Officer at Kezar Life Sciences, Inc, from SEC Form 4 filings since Aug 22, 2014.
Track record: 100% of 6 scored buys are up 5% or more since purchase, averaging +86%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |